These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A mechanistic review on GNAO1-associated movement disorder. Feng H; Khalil S; Neubig RR; Sidiropoulos C Neurobiol Dis; 2018 Aug; 116():131-141. PubMed ID: 29758257 [TBL] [Abstract][Full Text] [Related]
5. Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation. Silachev D; Koval A; Savitsky M; Padmasola G; Quairiaux C; Thorel F; Katanaev VL Acta Neuropathol Commun; 2022 Jan; 10(1):9. PubMed ID: 35090564 [TBL] [Abstract][Full Text] [Related]
6. Neonatal epileptic encephalopathy caused by de novo GNAO1 mutation misdiagnosed as atypical Rett syndrome: Cautions in interpretation of genomic test results. Gerald B; Ramsey K; Belnap N; Szelinger S; Siniard AL; Balak C; Russell M; Richholt R; De Both M; Claasen AM; Schrauwen I; Huentelman MJ; Craig DW; Rangasamy S; Narayanan V Semin Pediatr Neurol; 2018 Jul; 26():28-32. PubMed ID: 29961512 [TBL] [Abstract][Full Text] [Related]
7. [Effective Viral Delivery of Genetic Constructs to Neuronal Culture for Modeling and Gene Therapy of GNAO1 Encephalopathy]. Lunev EA; Shmidt AA; Vassilieva SG; Savchenko IM; Loginov VA; Marina VI; Egorova TV; Bardina MV Mol Biol (Mosk); 2022; 56(4):604-618. PubMed ID: 35964317 [TBL] [Abstract][Full Text] [Related]
8. De Novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy. Nakamura K; Kodera H; Akita T; Shiina M; Kato M; Hoshino H; Terashima H; Osaka H; Nakamura S; Tohyama J; Kumada T; Furukawa T; Iwata S; Shiihara T; Kubota M; Miyatake S; Koshimizu E; Nishiyama K; Nakashima M; Tsurusaki Y; Miyake N; Hayasaka K; Ogata K; Fukuda A; Matsumoto N; Saitsu H Am J Hum Genet; 2013 Sep; 93(3):496-505. PubMed ID: 23993195 [TBL] [Abstract][Full Text] [Related]
9. Clinical Cases and the Molecular Profiling of a Novel Childhood Encephalopathy-Causing Larasati YA; Solis GP; Koval A; Griffiths ST; Berentsen R; Aukrust I; Lesca G; Chatron N; Ville D; Korff CM; Katanaev VL Cells; 2023 Oct; 12(20):. PubMed ID: 37887313 [TBL] [Abstract][Full Text] [Related]
10. Pediatric Encephalopathy: Clinical, Biochemical and Cellular Insights into the Role of Gln52 of Solis GP; Kozhanova TV; Koval A; Zhilina SS; Mescheryakova TI; Abramov AA; Ishmuratov EV; Bolshakova ES; Osipova KV; Ayvazyan SO; Lebon S; Kanivets IV; Pyankov DV; Troccaz S; Silachev DN; Zavadenko NN; Prityko AG; Katanaev VL Cells; 2021 Oct; 10(10):. PubMed ID: 34685729 [TBL] [Abstract][Full Text] [Related]
11. [Encephalopathy GNAO1]. Bobylova MY; Volkov IV; Gumennik EV; Rachmanina OA; Abramov MO; Volkova OK; Bayborina TS; Petrukhin AS Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(1):122-130. PubMed ID: 36719128 [TBL] [Abstract][Full Text] [Related]
12. Genetic modeling of GNAO1 disorder delineates mechanisms of Gαo dysfunction. Wang D; Dao M; Muntean BS; Giles AC; Martemyanov KA; Grill B Hum Mol Genet; 2022 Feb; 31(4):510-522. PubMed ID: 34508586 [TBL] [Abstract][Full Text] [Related]
13. Progressive Movement Disorder in Brothers Carrying a GNAO1 Mutation Responsive to Deep Brain Stimulation. Kulkarni N; Tang S; Bhardwaj R; Bernes S; Grebe TA J Child Neurol; 2016 Feb; 31(2):211-4. PubMed ID: 26060304 [TBL] [Abstract][Full Text] [Related]